EPAM Systems, Inc. (EPAM) Q1 2025 Earnings Call Transcript — Neutral

EPAM   Seeking Alpha — May 08, 2025

EPAM Systems, Inc. (NYSE:EPAM ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Mike Rowshandel - Head of Investor Relations Arkadiy Dobkin - Chief Executive Officer and President Jason Peterson - Chief Financial Officer Conference Call Participants Bryan Bergin - TD Cowen Ramsey El-Assal - Barclays Maggie Nolan - William Blair David Grossman - Stifel Jonathan Lee - Guggenheim Jason Kupferberg - Bank of America Jamie Friedman - Susquehanna Puneet Jain - JP Morgan Darrin Peller - Wolfe Research Jim Schneider - Goldman Sachs Operator Good day, and welcome to EPAM Systems First Quarter 2025 …

image for news EPAM Systems, Inc. (EPAM) Q1 2025 Earnings Call Transcript

Lottery.com and Sports.com at Indianapolis Motor Speedway — Neutral

LTRY   GlobeNewsWire — May 08, 2025

INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (Nasdaq: LTRY, LTRYW) announces that Scottish driver Sebastian Murray is set to make his Indianapolis Grand Prix race debut this weekend, piloting the No. 2 Dream Racing Dubai Dallara for Andretti Cape in Rounds 3 and 4 of the 2025 INDY NXT by Firestone championship at the Indianapolis Motor Speedway.

image for news Lottery.com and Sports.com at Indianapolis Motor Speedway

Microsoft does not allow its employees to use an artificial intelligence app developed by Chinese AI startup Deepseek, due to concerns related to data vulnerability as well as Chinese propaganda, President Brad Smith said on Thursday.

image for news Microsoft doesn't allow its employees to use China's Deepseek-President

Long Runway Of Steady Growth In Korea For Coupang — Positive

CPNG   Seeking Alpha — May 08, 2025

Coupang's fulfillment-led strategy ensures unmatched speed, reliability, and consistency, creating a powerful moat in Korea's e-commerce market. The Wow membership flywheel, integrating Rocket Delivery, Coupang Eats, and Coupang Play, drives customer retention and spend, enhancing Coupang's ecosystem. Growth opportunities lie in expanding rural coverage in Korea, expanding spend per customer and international markets like Taiwan,.

image for news Long Runway Of Steady Growth In Korea For Coupang

PM Stock Up 6.9% Post Q1 Earnings: A Green Light for Investors? — Positive

PM   Zacks Investment Research — May 08, 2025

PM shows strong growth prospects, driven by its successful shift to smoke-free products, solid first-quarter results and optimistic guidance.

image for news PM Stock Up 6.9% Post Q1 Earnings: A Green Light for Investors?

UGI Q2 Earnings Top, Revenues Lag Estimates, 2025 EPS View Raised — Neutral

UGI   Zacks Investment Research — May 08, 2025

UGI's fiscal second-quarter earnings surpass estimates, while revenues are lower than expected. The company raises its fiscal 2025 EPS outlook.

image for news UGI Q2 Earnings Top, Revenues Lag Estimates, 2025 EPS View Raised

Novo Nordisk (NVO) is a Top Dividend Stock Right Now: Should You Buy? — Positive

NVO   Zacks Investment Research — May 08, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novo Nordisk (NVO) have what it takes?

image for news Novo Nordisk (NVO) is a Top Dividend Stock Right Now: Should You Buy?

Are You Looking for a High-Growth Dividend Stock? — Positive

UVSP   Zacks Investment Research — May 08, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Univest (UVSP) have what it takes?

image for news Are You Looking for a High-Growth Dividend Stock?

NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Capricor Therapeutics, Inc. ("Capricor Therapeutics, Inc.") (NASDAQ:CAPR) concerning possible violations of federal securities laws. Capricor issued a press release on May 5, 2025, announcing that after "the completion of a mid-cycle review meeting with the U.S. Food and Drug Administration (FDA) for the Company's Biologics License Application (BLA) seeking full approval for deramiocel, an investigational cell therapy, as a treatment for patients diagnosed with Duchenne muscular dystrophy (DMD) cardiomyopathy", the FDA had "confirmed its intent to hold …

image for news Levi & Korsinsky Investigates Possible Securities Fraud Violations by Capricor Therapeutics, Inc. (CAPR)

Royalty Pharma plc (RPRX) Q1 2025 Earnings Call Transcript — Neutral

RPRX   Seeking Alpha — May 08, 2025

Royalty Pharma plc (NASDAQ:RPRX ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants George Grofik - Senior Vice President and Head, Investor Relations and Communications Pablo Legorreta - Founder and CEO Marshall Urist - Executive Vice President and Head, Research and Investment Terry Coyne - Executive Vice President and CFO Chris Hite - Executive Vice President and Vice Chairman Conference Call Participants Hardik Parikh - JPMorgan Mike Nedelcovych - TD Cowen Terence Flynn - Morgan Stanley Geoff Meacham - Citi Jason Gerberry - Bank of America Securities Operator Ladies and gentlemen, thank you for standing …

image for news Royalty Pharma plc (RPRX) Q1 2025 Earnings Call Transcript

PayPal Q1: A Nice Fit To Buffett 10x Pretax Rule — Positive

PYPL   Seeking Alpha — May 08, 2025

PayPal Holdings stock reported strong financials for its fiscal Q1 2025 and described multiple growth drivers. Key growth drivers include a new checkout experience, Venmo expansion, AI integration, scaling omni mode, etc. However, PYPL stock trades at only 10.8x pretax earnings based on EPS guidance, very close to the threshold in Buffett's 10x pretax rule.

image for news PayPal Q1: A Nice Fit To Buffett 10x Pretax Rule

Akebia Therapeutics, Inc. (AKBA) Q1 2025 Earnings Call Transcript — Neutral

AKBA   Seeking Alpha — May 08, 2025

Akebia Therapeutics, Inc. (NASDAQ:AKBA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Mercedes Carrasco - Senior Director of Investor Relations John Butler - Chief Executive Officer Nick Grund - Chief Commercial Officer Erik Ostrowski - Chief Financial and Chief Business Officer Conference Call Participants Roanna Ruiz - Leerink Partners Roger Song - Jefferies Allison Bratzel - Piper Sandler Les Siloski - Truist Securities Operator Good day and thank you for standing by. Welcome to Akebia's First Quarter 2025 Financial Results Call.

image for news Akebia Therapeutics, Inc. (AKBA) Q1 2025 Earnings Call Transcript

IMTE Announces Receipt of Deficiency Letter from Nasdaq — Neutral

IMTE   PRNewsWire — May 08, 2025

NEW YORK , May 8, 2025 /PRNewswire/ -- Integrated Media Technology Limited (NASDAQ: IMTE) ("IMTE" or the "Company"), an Australia company that is engaged in the businesses of the trading in Halal products, the manufacture and sale of nano coated plates for filters, and the manufacturing and sale of electronic glass, today announced that it has received notification letter dated May 2, 2025 (the "Deficiency Letter") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq") notifying that the Company is no longer in compliance with the Nasdaq Listing Rule 5250(c)(1) for continued listing due to its …

image for news IMTE Announces Receipt of Deficiency Letter from Nasdaq

Kenvue, Inc. (KVUE) Q1 2025 Earnings Call Transcript — Neutral

KVUE   Seeking Alpha — May 08, 2025

Kenvue, Inc. (NYSE:KVUE ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Sofya Tsinis - Head of Investor Relations Thibaut Mongon - Chief Executive Officer and Director Paul Ruh - Chief Financial Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Peter Grom - UBS Andrea Teixeira - J.P. Morgan Anna Lizzul - Bank of America Keith Davis - Jefferies Nik Modi - RBC Capital Markets Filippo Falorni - Citi Javier Escalante - Evercore ISI Alec Legg - Canaccord Genuity Steve Powers - Deutsche Bank Korinne Wolfmeyer - Piper Sandler Operator Hello, and welcome to …

image for news Kenvue, Inc. (KVUE) Q1 2025 Earnings Call Transcript

Popular, Inc. Declares a Cash Dividend of $0.70 per Common Share — Neutral

BPOP   Business Wire — May 08, 2025

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Popular, Inc. (NASDAQ: BPOP) announced today that its Board of Directors has approved a quarterly cash dividend of $0.70 per share on its outstanding common stock. The dividend will be payable on July 1, 2025 to shareholders of record at the close of business on May 29, 2025. About Popular, Inc. Popular, Inc. (NASDAQ: BPOP) is the leading financial institution by both assets and deposits in Puerto Rico and ranks among the top 50 U.S. bank holding companie.

image for news Popular, Inc. Declares a Cash Dividend of $0.70 per Common Share

Veru Inc. (VERU) Q2 2025 Earnings Call Transcript — Neutral

VERU   Seeking Alpha — May 08, 2025

Veru Inc. (NASDAQ:VERU ) Q2 2025 Results Conference Call May 8, 2025 8:00 AM ET Company Participants Sam Fisch - Executive Director, Investor Relations and Corporate Communications Mitchell Steiner - Chairman, President and Chief Executive Officer Michele Greco - Chief Financial Officer and Chief Administrative Officer Gary Barnette - Chief Scientific Officer Conference Call Participants Anthea Li - Jefferies Gary Nachman - Raymond James William Wood - B. Riley Securities Leland Gershell - Oppenheimer Operator Good morning, ladies and gentlemen, and welcome to Veru Inc.'s Investor Conference Call.

image for news Veru Inc. (VERU) Q2 2025 Earnings Call Transcript

The Goodyear Tire & Rubber Company (NASDAQ:GT ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Greg Shank - Senior Director, IR Mark Stewart - CEO and President Christina Zamarro - EVP and CFO Conference Call Participants James Picariello - BNP Paribas Itay Michaeli - TD Cowen Ryan Brinkman - JPMorgan Emmanuel Rosner - Wolfe Research Wesley Brooks - HSBC Operator Good morning. My name is Stephanie, and I'll be your conference operator today.

image for news The Goodyear Tire & Rubber Company (GT) Q1 2025 Earnings Call Transcript

Viatris Inc.'s Q1 2025 earnings show declining revenues and profits, yet the stock rose nearly 10% due to stable full-year guidance and positive pipeline updates. The company's significant debt reduction from $22.4bn to $14.3bn came at the cost of selling key assets, raising concerns about long-term growth. Viatris faces challenges like tariffs, FDA warnings, and geopolitical uncertainties, impacting its operational stability and future profitability.

image for news Viatris Q1 Earnings Review: Shares Are Up, Time To Sell (Rating Downgrade)

Global Medical REIT, Inc. (GMRE) Q1 2025 Earnings Call Transcript — Neutral

GMRE   Seeking Alpha — May 08, 2025

Global Medical REIT, Inc. (NYSE:GMRE ) Q1 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Stephen Swett - Investor Relations Jeffrey Busch - Chief Executive Officer, Chairman and President Alfonzo Leon - Chief Investment Officer Robert Kiernan - Chief Financial Officer and Treasurer Conference Call Participants Wes Golladay - Baird Juan Sanabria - BMO Capital Markets Operator Greetings, and welcome to the Global Medical REIT First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.

image for news Global Medical REIT, Inc. (GMRE) Q1 2025 Earnings Call Transcript

Middleby's Q1 Earnings Surpass Estimates While Revenues Miss — Neutral

MIDD   Zacks Investment Research — May 08, 2025

MIDD's first-quarter 2025 net sales decrease 2% year over year on account of the lackluster performance of Commercial Foodservice and Food Processing segments.

image for news Middleby's Q1 Earnings Surpass Estimates While Revenues Miss